Focussing on its role as a ‘tumor suppressor’, inhibition of PP2A induces tumorigenesis by phosphorylation of components of pathways involved in cancer cell growth, such as extracellular signal related kinase (ERK), p38, Akt, and NF-κB [8,9]. The gene discussed is PTPA; the disease is neoplasm.